Pulsenmore Ltd.
- PLSM ยท Nasdaq
- Surgical & Medical Instruments & Apparatus
- Israel, Israel
- 63 employees
- CIK 0002064764
Updated from SEC filings through
Top things to know
Executives
- Elazar Sonnenschein Chief Executive Officer Form 3, March 18, 2026
- Eran Hirsh Chief Financial Officer Form 3, March 18, 2026
- David Woods Chief Commercial Officer Form 4, October 21, 2026
- Meir Shmouely VP Software Development Form 3, March 18, 2026
- Michael Hamelsdorf GC & Corporate Secretary Form 3, March 18, 2026
- Minelu Sonnenschein VP R&D Form 3, March 18, 2026
Pulsenmore Ltd. is a U.S. public company in surgical & medical instruments & apparatus (SIC 3841), headquartered in Israel, Israel. It trades as PLSM on Nasdaq. Revenue was $12.5M in the fiscal year ending December 31, 2025. It reported about 63 employees. Elazar Sonnenschein is Chief Executive Officer.
Five-year financials
| Metric | FY2025 |
|---|---|
| Revenue | $12.5M 20-F, 2026-03-30 |
| Operating income | Not on file |
| SG&A | Not on file |
| Net income | -$5.0M 20-F, 2026-03-30 |
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| Elazar Sonnenschein | Chief Executive Officer | Form 3, March 18, 2026 |
| Eran Hirsh | Chief Financial Officer | Form 3, March 18, 2026 |
| David Woods | Chief Commercial Officer | Form 4, October 21, 2026 |
| Meir Shmouely | VP Software Development | Form 3, March 18, 2026 |
| Michael Hamelsdorf General Counsel & Company Secretary at Pulsenmore Ltd. - Master of Law - LLM at Bar-Ilan University | GC & Corporate Secretary | Form 3, March 18, 2026 |
| Minelu Sonnenschein | VP R&D | Form 3, March 18, 2026 |
What Pulsenmore Ltd. does
Pulsenmore (NASDAQ and TASE: PLSM) is a world leader in self-scan ultrasound devices for remote clinical diagnosis and screening.
Company website description, 10-K for the year ending November 7, 2026
Shares and governance
| Shares outstanding | 6.5 million (as of March 15, 2026) | 20-F, March 30, 2026 |
|---|---|---|
| Auditor | Kesselman & Kesselman (Tel-Aviv, Israel) | Latest 10-K |
Insider trades
Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.
| Date | Insider | Trade | Shares | Value | Source |
|---|---|---|---|---|---|
| November 4, 2026 | Elazar Sonnenschein Chief Executive Officer | Buy | 9,259 | $16K | Form 4, November 5, 2026 |
Recent 8-K events
No 8-K filings on file.
Frequently asked questions about Pulsenmore Ltd.
- What does Pulsenmore Ltd. do?
- In its own words, from Item 1 of its 10-K: "Pulsenmore (NASDAQ and TASE: PLSM) is a world leader in self-scan ultrasound devices for remote clinical diagnosis and screening."
- What is Pulsenmore Ltd.'s revenue?
- $12.5M for the fiscal year ending December 31, 2025, from its 20-F filed March 30, 2026.
- Is Pulsenmore Ltd. profitable?
- Pulsenmore Ltd. reported net income of -$5.0M for the fiscal year ending December 31, 2025.
- How many employees does Pulsenmore Ltd. have?
- About 63 as of December 31, 2025, as stated in its annual report.
- Who is the CEO of Pulsenmore Ltd.?
- Elazar Sonnenschein, Chief Executive Officer, as named in a 3 filed March 18, 2026.
- Who is the CFO of Pulsenmore Ltd.?
- Eran Hirsh, Chief Financial Officer, as named in a 3 filed March 18, 2026.
- Where is Pulsenmore Ltd. headquartered?
- Israel, Israel.
- What is Pulsenmore Ltd.'s stock ticker?
- PLSM on Nasdaq.
- What industry is Pulsenmore Ltd. in?
- Surgical & Medical Instruments & Apparatus, SIC code 3841.
- What is Pulsenmore Ltd.'s website?
- pulsenmore.com.
- Is Pulsenmore Ltd. a public company?
- Yes. Pulsenmore Ltd. files with the SEC under CIK 0002064764 and trades as PLSM.
- Who audits Pulsenmore Ltd.?
- Kesselman & Kesselman, Tel-Aviv, Israel, as named in its latest annual report (10-K).
- How many shares of Pulsenmore Ltd. are outstanding?
- 6.5 million shares as of March 15, 2026, from its 20-F filed March 30, 2026.
- Have Pulsenmore Ltd. insiders traded stock recently?
- Since November 4, 2026, officers and directors reported 0 open-market sales and 1 purchase worth about $16K on Forms 4 and 5. The most recent: Elazar Sonnenschein (Chief Executive Officer) bought 9,259 shares on November 4, 2026.